<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1209671</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: &#x201c;Omics&#x201d;- revolution in elucidating the virulence and resistance in <italic>Staphylococcus aureus</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Nurjadi</surname>
<given-names>Dennis</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/688477"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tkadlec</surname>
<given-names>Jan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1202722"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boutin</surname>
<given-names>S&#xe9;bastien</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/121946"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vandenesch</surname>
<given-names>Fran&#xe7;ois</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/33067"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Infectious Diseases and Microbiology, University of L&#xfc;beck</institution>, <addr-line>L&#xfc;beck</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Medical Microbiology, Charles University, 2nd Faculty of Medicine and Motol University Hospital</institution>, <addr-line>Prague</addr-line>, <country>Czechia</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>CIRI, Centre International de Recherche en Infectiologie, Universit&#xe9; de Lyon, Inserm, U1111, Universit&#xe9; Claude Bernard Lyon 1, Centre National de la Recherche Scientifique (CNRS), UMR5308, &#xc9;cole Normale Sup&#xe9;rieure (ENS) de Lyon</institution>, <addr-line>Lyon</addr-line>, <country>France</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Centre National de R&#xe9;f&#xe9;rence des Staphylocoques, Institut des Agents Infectieux, Hospices Civils de Lyon</institution>, <addr-line>Lyon</addr-line>, <country>France</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Jon Skare, Texas A&amp;M Health Science Center, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Dennis Nurjadi, <email xlink:href="mailto:dennis.nurjadi@uni-luebeck.de">dennis.nurjadi@uni-luebeck.de</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1209671</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Nurjadi, Tkadlec, Boutin and Vandenesch</copyright-statement>    <copyright-year>2023</copyright-year>
<copyright-holder>Nurjadi, Tkadlec, Boutin and Vandenesch</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>    <related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/19090" ext-link-type="uri">Editorial on the Research Topic <article-title>&#x201c;Omics&#x201d;- revolution in elucidating the virulence and resistance in <italic>Staphylococcus aureus</italic>
</article-title>
</related-article>
<kwd-group>
<kwd>
<italic>Staphylococcus aureus</italic>
</kwd>
<kwd>omics</kwd>
<kwd>USA300</kwd>
<kwd>panton-valentine leukocidin</kwd>
<kwd>resistance and virulence</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="9"/>
<page-count count="2"/>
<word-count count="750"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>
<italic>Staphylococcus aureus</italic> is one of the most common causes of bacterial infections in humans, and the bacterial pathogen with the highest number of attributable deaths (<xref ref-type="bibr" rid="B3">Collaborators, 2022</xref>). The human nasal cavity serves as the natural reservoir for <italic>S. aureus</italic>. Although many healthy individuals are colonized with <italic>S. aureus</italic>, only some develop infections (<xref ref-type="bibr" rid="B9">Wertheim et&#xa0;al., 2005</xref>). The transition from a commensal to an opportunistic pathogen is not fully understood, but virulence factors likely play a significant role in initiating and facilitating infection processes (<xref ref-type="bibr" rid="B5">Howden et&#xa0;al., 2023</xref>). This Research Topic features articles showcasing the application of cutting-edge molecular biology methods (&#x201c;Omics&#x201d;) to elucidate the virulence and resistance of <italic>S. aureus</italic>.</p>
<p>The convergence of resistance and virulence is an intriguing phenomenon increasingly observed in many bacterial species (<xref ref-type="bibr" rid="B6">Li et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B1">Biggel et&#xa0;al., 2022</xref>). One of the archetypes of this convergence is the emergence of virulent community-associated methicillin-resistant <italic>S. aureus</italic> (MRSA), USA300 strains (<xref ref-type="bibr" rid="B7">Nimmo, 2012</xref>).To shed light on the events that shaped the evolution of this lineage, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2023.1081070">Bianco et&#xa0;al.</ext-link> investigated the evolution of the pandemic MRSA strain USA300 by analyzing and comparing genomic sequences of circulating USA300 strains and USA300 strains that predate the dominance of this expansive clone. They notably uncovered a pre-epidemic branching clade consisting of (already Panton-Valentine leukocidin (PVL)-positive) both methicillin-susceptible <italic>S. aureus</italic> (MSSA) and MRSA isolates circulating around the world that diverged from the USA300 lineage prior to the establishment of the South American and North American epidemics.</p>
<p>The treatment of infections caused by <italic>S. aureus</italic> can be challenging, as recurrences or chronicity may occur despite appropriate therapy (<xref ref-type="bibr" rid="B8">Tuchscherr et&#xa0;al., 2020</xref>). The study by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2022.817841">Klein et&#xa0;al.</ext-link> found that even when belonging to the same clone, <italic>S. aureus</italic> isolated from different body sites and infection foci may exhibit differences in virulence and resistance phenotypes. This phenotypic plasticity and heterogeneity can be attributed to the integration of Sa3int bacteriophages into the &#x3b2;-hemolysin (<italic>hlb</italic>) gene, which results in the truncation of the <italic>hlb</italic> gene and the insertion of genes encoding staphylokinase (<italic>sak</italic>) and staphylococcal complement inhibitor (<italic>scn</italic>), leading to a highly plastic immune evasive phenotype.</p>
<p>Blocking bacterial virulence to promote pathogen killing and elimination by the immune system is an interesting alternative treatment approach (<xref ref-type="bibr" rid="B4">Ford et&#xa0;al., 2020</xref>). The study by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2022.746746">Zhou et&#xa0;al.</ext-link> investigated the role of small RNA SprC using RNASeq for transcriptomics analysis on the metabolism and virulence of <italic>S. aureus</italic> N315. Over 2,497 identified transcripts, the SprC-mutant N315 <italic>S. aureus</italic> exhibited 23 downregulated differentially expressed genes, mainly related to metabolism and pathogenesis. Considering the emergence of drug resistance in <italic>S. aureus</italic>, such &#x201c;pathoblockers&#x201d; may be a promising alternative treatment strategy.</p>
<p>Traditionally, the clinical severity of <italic>S. aureus</italic> infections is associated with the presence or absence of certain genes coding some of the various <italic>S. aureus</italic> virulence factors (<xref ref-type="bibr" rid="B5">Howden et&#xa0;al., 2023</xref>). However, the impact of the expression levels of these virulence factors has been underexplored, largely due to the lack of high-throughput quantification methods for virulence proteins. In the study conducted by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2023.1162617">Pivard et&#xa0;al.</ext-link>, the authors investigated the quantitative virulomes of 136 <italic>S. aureus</italic> isolates using a targeted proteomic approach. Their findings revealed that several virulence factors, including PVL, were associated with severity parameters in a dose-dependent manner, providing the proof of concept that &#x201c;expression matters&#x201d; in pathogen virulence and can be inferred from <italic>in vitro</italic> culture of the corresponding strain.</p>
<p>Nasal colonization with <italic>S. aureus</italic> is associated with an increased propensity to acquire infections (<xref ref-type="bibr" rid="B2">Bode et&#xa0;al., 2010</xref>). Therefore, understanding the mechanisms of persistent nasal colonization may help identify novel targets and strategies to decolonize high-risk patients. In their study, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2022.874138">Salgado et&#xa0;al.</ext-link> used serial passaging of a murine colonization model and genome sequencing to demonstrate that changes were found in genes associated with the cell surface and metabolism, which might indicate niche adaptation in <italic>S. aureus</italic> to promote long-term colonization.</p>
<p>The articles presented in this Research Topic showcase the promising use of &#x201c;OMICs&#x201d; technologies in advancing research on <italic>S. aureus</italic> virulence and resistance. Specifically, the application of transcriptomics and proteomics adds a new functional and mechanistic dimension to elucidating the pathophysiology of <italic>S. aureus</italic> infections. By gaining a deeper understanding of the correlation between virulence factors and clinical outcomes, we may be able to improve diagnostic and therapeutic strategies for <italic>S. aureus</italic> infections.</p>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
</body>
<back>
<sec id="s2" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s3" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biggel</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Moons</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Goossens</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Van Puyvelde</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Convergence of virulence and antimicrobial resistance in increasingly prevalent escherichia coli ST131 papGII+ sublineages</article-title>. <source>Commun. Biol.</source> <volume>5</volume>, <fpage>752</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s42003-022-03660-x</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bode</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Kluytmans</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Wertheim</surname> <given-names>H. F.</given-names>
</name>
<name>
<surname>Bogaers</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Vandenbroucke-Grauls</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Roosendaal</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Preventing surgical-site infections in nasal carriers of staphylococcus aureus</article-title>. <source>New Engl. J. Med.</source> <volume>362</volume>, <fpage>9</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa0808939</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>Collaborators, G.B.D.a.R</collab>
</person-group> (<year>2022</year>). <article-title>Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019</article-title>. <source>Lancet</source> <volume>400</volume>, <fpage>2221</fpage>&#x2013;<lpage>2248</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(22)02185-7</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ford</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Hurford</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Cassat</surname> <given-names>J. E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antivirulence strategies for the treatment of staphylococcus aureus infections: a mini review</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>, <elocation-id>632706</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.632706</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howden</surname> <given-names>B. P.</given-names>
</name>
<name>
<surname>Giulieri</surname> <given-names>S. G.</given-names>
</name>
<name>
<surname>Wong Fok Lung</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Baines</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Sharkey</surname> <given-names>L. K.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J. Y. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Staphylococcus aureus host interactions and adaptation</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>1-16</volume>, <fpage>380</fpage>&#x2013;<lpage>395</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-023-00852-y</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Convergence of carbapenem resistance and hypervirulence leads to high mortality in patients with postoperative klebsiella pneumoniae meningitis</article-title>. <source>J. Glob Antimicrob. Resist.</source> <volume>27</volume>, <fpage>95</fpage>&#x2013;<lpage>100</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jgar.2021.02.035</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nimmo</surname> <given-names>G. R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant staphylococcus aureus</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>18</volume>, <fpage>725</fpage>&#x2013;<lpage>734</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1469-0691.2012.03822.x</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuchscherr</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Loffler</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Proctor</surname> <given-names>R. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Persistence of staphylococcus aureus: multiple metabolic pathways impact the expression of virulence factors in small-colony variants (SCVs)</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>, <elocation-id>1028</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2020.01028</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wertheim</surname> <given-names>H. F.</given-names>
</name>
<name>
<surname>Melles</surname> <given-names>D. C.</given-names>
</name>
<name>
<surname>Vos</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Van Leeuwen</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Van Belkum</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Verbrugh</surname> <given-names>H. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>The role of nasal carriage in staphylococcus aureus infections</article-title>. <source>Lancet Infect. Dis.</source> <volume>5</volume>, <fpage>751</fpage>&#x2013;<lpage>762</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1473-3099(05)70295-4</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>